Safa O, Parkin S M, Matthew A M, Bibby M C
Department of Biomedical Sciences, University of Bradford, West Yorkshire, U.K.
Anticancer Res. 1997 Jan-Feb;17(1A):37-43.
Hexadecylphosphocholine (HPC) is active against experimental and clinical breast cancer in vivo but the precise mechanisms involved are not fully understood. Studies in this and other laboratories have demonstrated that HPC has very significant activity against MT-1 human mammary xenografts in nude mice and preliminary studies have indicated immunomodulatory effects. The aims of this study were to investigate the influence of HPC on immune cell populations in nude mice bearing MT-1 xenografts and the effects of HPC on MT-1 xenograft vascularisation. After treatment, significant increases in the number of cells were observed in the spleen paracortex and cortex and the follicles were more developed compared with lymph nodes from untreated mice. Immune cell populations in spleens from untreated MT-1 tumour bearing nude mice were compared with those from HPC treated mice. After HPC treatment, increases in the macrophage and T cell populations as well as T cell subsets were observed in spleens. Histological examination of treated tumours showed the presence of giant cells and large lytic areas. Immunostaining revealed increases in endothelial cells (p < 0.005) associated with massive infiltration of M phi, T cells and B cells. The results suggest that HPC affects the development of immune cells in the secondary immune tissues of nude mice. An increase in tumour vasculature appears to be accompanied by infiltration of immune cells into the tumour.
十六烷基磷胆碱(HPC)在体内对实验性和临床乳腺癌具有活性,但具体机制尚未完全明确。本实验室及其他实验室的研究表明,HPC对裸鼠体内的MT-1人乳腺异种移植瘤具有显著活性,初步研究显示其具有免疫调节作用。本研究旨在探讨HPC对携带MT-1异种移植瘤的裸鼠免疫细胞群体的影响以及HPC对MT-1异种移植瘤血管生成的作用。治疗后,与未治疗小鼠的淋巴结相比,观察到脾脏副皮质和皮质中的细胞数量显著增加,滤泡更发达。将未治疗的携带MT-1肿瘤的裸鼠脾脏中的免疫细胞群体与接受HPC治疗的小鼠的进行比较。HPC治疗后,脾脏中巨噬细胞和T细胞群体以及T细胞亚群均增加。对治疗后的肿瘤进行组织学检查发现存在巨细胞和大片溶解区域。免疫染色显示内皮细胞增加(p < 0.005),伴有巨噬细胞、T细胞和B细胞的大量浸润。结果表明,HPC影响裸鼠二级免疫组织中免疫细胞的发育。肿瘤血管生成增加似乎伴随着免疫细胞浸润到肿瘤中。